Reyes, K. R., Shipp, C. A., Ding, C. C., Chan, E., Zhu, X., Cai, E. Y., Fitzgerald, K. N., Desai, A., Hsu, S. C., Kouchkovsky, I. D., Younger, N. S., Kwon, D. H., Aggarwal, R. R., Seyedin, S. N., Porten, S. P., Chou, J., Friedlander, T. W., Chu, C. E., Koshkin, V. S. (2026). Association of HER2 and NECTIN4 expression with clinical outcomes in patients (pts) with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin +/- pembrolizumab (EVP).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.796